McBride W H, Howie S E
Br J Cancer. 1986 Jun;53(6):707-11. doi: 10.1038/bjc.1986.122.
Small size inocula (10(1)-10(3) cells) of cells from a syngeneic methylcholanthrene-induced fibrosarcoma (FSA) induced tolerance when injected s.c. into C3Hf mice. Mice were unable to respond to subsequent challenge with moderate, immunogenic doses of FSA. Tolerance was demonstrated in an in vivo transfer (Winn) assay and an in vitro tumour-specific TH cell assay. Low zone tolerance was associated with the presence of tumour-specific TS cells in the spleen. Moderate size inocula (10(4)-10(6) FSA cells) were immunogenic but larger cell doses (greater than 10(6)) were again tolerogenic. In the high zone, tolerance was associated with both tumour-specific TS cells and non T suppressor cells that were not tumour-specific. These results support the view that immunogenic tumours, as they grow from small cell numbers, might be able to escape host surveillance by specifically tolerizing the immune system. They also suggest that large tumour burdens can interfere with the host's immune response by inducing suppressor cells.
将同基因的甲基胆蒽诱导的纤维肉瘤(FSA)的小剂量接种物(10¹-10³个细胞)皮下注射到C3Hf小鼠体内时可诱导耐受性。小鼠对随后中等免疫原性剂量的FSA攻击无反应。在体内转移(Winn)试验和体外肿瘤特异性TH细胞试验中证实了耐受性。低区耐受性与脾脏中肿瘤特异性TS细胞的存在有关。中等剂量接种物(10⁴-10⁶个FSA细胞)具有免疫原性,但更大的细胞剂量(大于10⁶)再次具有耐受性。在高区,耐受性与肿瘤特异性TS细胞和非肿瘤特异性的非T抑制细胞均有关。这些结果支持这样的观点,即免疫原性肿瘤在从小细胞数量开始生长时,可能能够通过特异性耐受免疫系统来逃避宿主监视。它们还表明,大的肿瘤负荷可通过诱导抑制细胞来干扰宿主的免疫反应。